GenNext Technologies and NeoProteomics have joined forces to advance biomolecular footprinting know-how and utility in biopharmaceutical and structural biology research. Neo is a world-recognized leader in footprinting services for biopharmaceutical and structural biology research supporting numerous partner companies and research laboratories worldwide. GenNext is the world’s only provider of footprinting instruments, software, and accessories that enable higher order structural analysis to be performed on compact, powerful, and intuitive benchtop instrumentation. Together, we are collaborating to help researchers increase the speed and accuracy of their biologics and small molecule drug development.

Learn about NeoProteomics here.